Authors’ reply to Creagh-Brown

Creagh-Brown's point that [beta] blockers should be offered to patients with left ventricular systolic dysfunction and chronic obstructive pulmonary disease without reversibility on spirometry is valid. 1 2 3 But even cardioselective [beta] blockers can reduce forced expiratory volume in one se...

Full description

Saved in:
Bibliographic Details
Published in:BMJ (Online) 2014-05, Vol.348 (may19 3), p.g3322-g3322
Main Authors: Williams, Rupert P, cardiology, specialist registrar in, Oakeshott, Pippa
Format: Article
Language:English
Subjects:
Beta blockers
CHRONIC HEART FAILURE
Chronic obstructive pulmonary disease
Female
Heart failure
Heart Failure - diagnosis
Heart Failure - drug therapy
Humans
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Creagh-Brown's point that [beta] blockers should be offered to patients with left ventricular systolic dysfunction and chronic obstructive pulmonary disease without reversibility on spirometry is valid. 1 2 3 But even cardioselective [beta] blockers can reduce forced expiratory volume in one second (FEV1) in patients with moderate to severe chronic obstructive pulmonary disease. 4 Competing interests: Bisoprolol in patients with heart failure and moderate to severe chronic obstructive pulmonary disease: a randomized controlled trial.
ISSN:0959-8138
1756-1833
1756-1833
DOI:10.1136/bmj.g3322